-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
One of the main tools to combat malaria in Africa is the use of rapid diagnostic tests, which are part of the "test-treat-track" strategy of Ethiopia, the second most populous country in Africa
The study, published in the journal Nature Microbiology , shows that the parasite has two genetic mutations that allow it to escape detection
"This is a serious problem for malaria control.
The co-corresponding authors are Sindew M.
This research project was carried out in cooperation with the Ethiopian Institute of Public Health and the World Health Organization
In collaboration with Dr.
"Our work shows that phrrp3 deletion has appeared independently multiple times over the course of many years," said Parr, a member of the United Nations University Institute of Global Health and Infectious Diseases
In the " Nature Microbiology " paper, the author asked: "Compared with genetically complete parasites, what other advantages do pfhrp2/3 deletion parasites have? Our limited biological understanding of these deletions makes this problem.
Parr said: "We have found clear evidence that recently at the border between Ethiopia and Sudan and Eritrea, parasites have evolved to evade the rapid diagnostic test for malaria
Feleke said: "The results of this joint study prompted us to change the diagnostic testing policy in the most affected areas of Ethiopia, from detecting hrp2/3 RDTs to non-hrp2/3 targeted RDTs
In addition, along with several other unpublished reports, this research prompted the World Health Organization to issue a statement of concern
Cunningham said: “WHO recommends that all malaria-endemic countries start and maintain monitoring of the pfhrp2/3 deletion, and respond appropriately after confirming the deletion, to prevent unnecessary morbidity and death, and to ensure the achievement of malaria elimination.
###